STRATEC BIOMEDICAL AG/ DE000STRA555 /
| 2024-11-07 12:33:16 PM | Chg. -0.65 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 32.20EUR | -1.98% | 30 Turnover: 966 |
-Bid Size: - | -Ask Size: - | 395.07 mill.EUR | 1.69% | 30.37 |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 1.07 EUR | -55.60% |
| EPS Diluted: | - EUR | -55.42% |
| Revenues per Share: | 21.55 EUR | -4.81% |
| Book Value per Share: | 19.19 EUR | 3.40% |
| Cash Flow per Share: | - EUR | - |
| Dividend per Share: | 0.55 EUR | -43.30% |
| Total | in mill. | |
| Revenues: | 261.91 EUR | -4.62% |
| Net Income: | 13.06 EUR | -55.27% |
| Operating Cash Flow: | - EUR | - |
| Cash and Cash Equivalents: | 33.53 EUR | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 30.37 | 42.57 |
| P/S Ratio: | 1.51 | 2.11 |
| P/BV ratio: | 1.69 | 2.37 |
| P/CF Ratio: | - | - |
| PEG: | -0.55 | -0.77 |
| Earnings Yield: | 3.29% | 2.35% |
| Dividend Yield: | 1.69% | 1.21% |
| Market Capitalization | ||
| Market Capitalization: | 395.07 mill. EUR | 553.7 mill. EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | 253,411.2348 EUR | 355,165.5921 EUR |
| Shares Outstanding: | 12.16 mill. | |
Profitability
| Gross Profit Margin: | 24.76% |
| EBIT Margin: | 8.54% |
| Net Profit Margin: | 4.99% |
| Return on Equity: | 5.60% |
| Return on Assets: | 2.80% |
Financial Strength
| Liquidity I / Cash Ratio: | 34.77% |
| Liquidity II / Quick Ratio: | 94.97% |
| Liquidity III / Current Ratio: | 257.15% |
| Debt / Equity Ratio: | 99.97% |
| Dynam. Debt / Equity Ratio: | - |
Efficiency
| Employees: | 1,559 |
| Personal Expenses / Employee: | - EUR |
| Revenues / Employee: | 167,998.72 EUR |
| Net Income / Employee: | 8,377.16 EUR |
| Total Assets / Employee: | 299,275.18 EUR |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | IFRS |
| Currency: | EUR |
